Lin28 promotes Her2 expression and Lin28/Her2 predicts poorer survival in gastric cancer

被引：17

作者：

Wang, Qinchuan ^{[1
]}

Zhou, Jichun ^{[1
]}

Guo, Jufeng ^{[1
]}

Teng, Rongyue ^{[1
]}

Shen, Jianguo ^{[1
]}

Huang, Yasheng ^{[2
,3
]}

Xie, Shuduo ^{[1
]}

Wei, Qun ^{[1
]}

Zhao, Wenhe ^{[1
]}

Chen, Wenjun ^{[1
]}

Yuan, Xiaoming ^{[1
]}

Chen, Yongxia ^{[1
]}

Wang, Linbo ^{[1
,2
,3
]}

机构：

[1] Zhejiang Univ, Dept Surg Oncol, Affiliated Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310008, Zhejiang, Peoples R China

[2] Biomed Res Ctr, Hangzhou 310016, Zhejiang, Peoples R China

[3] Key Lab Biotherapy Zhejiang Prov, Hangzhou 310016, Zhejiang, Peoples R China

来源：

TUMOR BIOLOGY | 2014年 / 35卷 / 11期

基金：

高等学校博士学科点专项科研基金;

关键词：

Gastric cancer; Lin28; Her2; Prognosis; Modulation; GASTROESOPHAGEAL JUNCTION; ESTROGEN-RECEPTOR; LET-7; MICRORNA; BREAST-CANCER; CHEMOTHERAPY; REGULATOR; CELLS;

D O I：

10.1007/s13277-014-2481-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The main purpose of this study is to investigate the interactions between Lin28 and Her2 in gastric cancer. Lin28 and Her2 expression were evaluated in surgically resected samples of 298 gastric cancer patients using immunohistochemical staining. The correlations between Lin28/Her2 expression and clinical variables were retrospectively analyzed. The mRNA level of LIN28 and HER2 was detected by reverse-transcriptase polymerase chain reaction. Among all gastric cancer patients, 33.9 % (101/298) were determined as Her2-positive, and 43.0 % (128/298) were defined as Lin28-positive. Lin28 was significantly associated with Her2, advanced tumor stage, lesion size, and Ki67 level (p < 0.05 for each). Kaplan-Meier analysis illustrated that both Lin28 and Her2 are poor prognostic factors in gastric cancer; Lin28(+)/Her2(+) patients have the poorest survival (median survival = 17 months, p < 0.01). Multivariate Cox analysis showed that Lin28 is a significant prognostic factor (hazard ratio (HR) = 1.79, 95 % confidence interval (CI) 1.23-2.62). Further stratification analysis indicated that Lin28 may be a prognostic factor in chemotherapy. In vitro data on MKN-28 and MKN-45 cells showed that Lin28 can upregulate Her2 expression at translational level. Both Lin28 and Her2 are poor prognostic factors in gastric cancer. Lin28 may regulate Her2 post-transcriptionally in gastric cancer cells, which indicates it might be a potential target in the treatment of gastric cancer.

引用

页码：11513 / 11521

页数：9

共 34 条

[1] Gastric Cancer Clinical Practice Guidelines in Oncology™ [J].

Ajani, Jaffer A. ;

Barthel, James S. ;

Bekaii-Saab, Tanios ;

Bentrem, David J. ;

D'Amico, Thomas A. ;

Das, Prajnan ;

Denlinger, Crystal ;

Fuchs, Charles S. ;

Gerdes, Hans ;

Hayman, James A. ;

Hazard, Lisa ;

Hofstetter, Wayne L. ;

Ilson, David H. ;

Keswani, Rajesh N. ;

Kleinberg, Lawrence R. ;

Korn, Michael ;

Meredith, Kenneth ;

Mulcahy, Mary F. ;

Orringer, Mark B. ;

Osarogiagbon, Raymond U. ;

Posey, James A. ;

Sasson, Aaron R. ;

Scott, Walter J. ;

Shibata, Stephen ;

Strong, Vivian E. M. ;

Washington, Mary Kay ;

Willett, Christopher ;

Wood, Douglas E. ;

Wright, Cameron D. ;

Yang, Gary .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (04) :378-409

[2] Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial [J].

Albain, Kathy S. ;

Barlow, William E. ;

Shak, Steven ;

Hortobagyi, Gabriel N. ;

Livingston, Robert B. ;

Yeh, I-Tien ;

Ravdin, Peter ;

Bugarini, Roberto ;

Boehner, Frederick L. ;

Davidson, Nancy E. ;

Sledge, George W. ;

Winer, Eric P. ;

Hudis, Clifford ;

Ingle, James N. ;

Perez, Edith A. ;

Pritchard, Kathleen I. ;

Shepherd, Lois ;

Gralow, Julie R. ;

Yoshizawa, Carl ;

Allred, D. Craig ;

Osborne, C. Kent ;

Hayes, Daniel F. .

LANCET ONCOLOGY, 2010, 11 (01) :55-65

[3]

[Anonymous], CA CANC J CLIN, DOI DOI 10.3322/CAAC.20107

[4]

Bang YJ, 2010, LANCET, V376, P1302

[5] Personalized Cancer Medicine: Molecular Diagnostics, Predictive Biomarkers, and Drug Resistance [J].

de Castro, D. Gonzalez ;

Clarke, P. A. ;

Al-Lazikani, B. ;

Workman, P. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (03) :252-259

[6] MiR-199b-5p targets HER2 in breast cancer cells [J].

Fang, Chen ;

Zhao, Yu ;

Guo, Baoyu .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (07) :1457-1463

[7] The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis [J].

Fassan, Matteo ;

Pizzi, Marco ;

Realdon, Stefano ;

Balistreri, Mariangela ;

Guzzardo, Vincenza ;

Zagonel, Vittonina ;

Castoro, Carlo ;

Mastracci, Luca ;

Farinati, Fabio ;

Nitti, Donato ;

Zaninotto, Giovanni ;

Rugge, Massimo .

HUMAN PATHOLOGY, 2013, 44 (09) :1804-1810

[8] Lin28 regulates HER2 and promotes malignancy through multiple mechanisms [J].

Feng, Chen ;

Neumeister, Veronique ;

Ma, Wei ;

Xu, Jie ;

Lu, Lingeng ;

Bordeaux, Jennifer ;

Maihle, Nita J. ;

Rimm, David L. ;

Huang, Yingqun .

CELL CYCLE, 2012, 11 (13) :2486-2494

[9] Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial [J].

Gordon, M. A. ;

Gundacker, H. M. ;

Benedetti, J. ;

Macdonald, J. S. ;

Baranda, J. C. ;

Levin, W. J. ;

Blanke, C. D. ;

Elatre, W. ;

Weng, P. ;

Zhou, J. Y. ;

Lenz, H. J. ;

Press, M. F. .

ANNALS OF ONCOLOGY, 2013, 24 (07) :1754-1761

[10]

Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1

← 1 2 3 4 →